(19)
(11) EP 4 798 724 A1

(12)

(43) Date of publication:
02.09.2026 Bulletin 2026/36

(21) Application number: 24789808.3

(22) Date of filing: 09.10.2024
(51) International Patent Classification (IPC): 
C12N 15/86(2006.01)
C12N 5/00(2006.01)
(52) Cooperative Patent Classification (CPC):
C12N 15/86; C12N 2750/14143; C12N 2750/14151; C12N 5/0018; C12N 2501/727; C12N 2501/405; C12N 2501/999; C12N 2501/065
(86) International application number:
PCT/EP2024/078437
(87) International publication number:
WO 2025/087695 (01.05.2025 Gazette 2025/18)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
GE KH MA MD TN

(30) Priority: 23.10.2023 US 202363592330 P

(71) Applicant: Ascend Advanced Therapies Ltd
Cheshire WA14 2DT (GB)

(72) Inventors:
  • REID, Christopher Andrew
     (GB)
  • MANDEGAR, Mohammad Ali
     (GB)
  • GRAFTON, Francis Nadine
     (GB)

(74) Representative: J A Kemp LLP 
80 Turnmill Street
London EC1M 5QU
London EC1M 5QU (GB)

   


(54) METHOD FOR PRODUCING RECOMBINANT ADENO-ASSOCIATED VIRUS PARTICLES